Nonoperating Income (Expense) in USD of Qualigen Therapeutics, Inc. from Q3 2014 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Qualigen Therapeutics, Inc. quarterly/annual Nonoperating Income (Expense) history and change rate from Q3 2014 to Q3 2025.
  • Qualigen Therapeutics, Inc. Nonoperating Income (Expense) for the quarter ending September 30, 2025 was -$608K, a 15.2% decline year-over-year.
  • Qualigen Therapeutics, Inc. Nonoperating Income (Expense) for the twelve months ending September 30, 2025 was -$48.5K, a 95.5% increase year-over-year.
  • Qualigen Therapeutics, Inc. annual Nonoperating Income (Expense) for 2024 was -$391K, a 66.7% increase from 2023.
  • Qualigen Therapeutics, Inc. annual Nonoperating Income (Expense) for 2023 was -$1.17M, a 235% decline from 2022.
  • Qualigen Therapeutics, Inc. annual Nonoperating Income (Expense) for 2022 was $873K, a 81.7% decline from 2021.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Change (%)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Change (%)

Qualigen Therapeutics, Inc. Quarterly Nonoperating Income (Expense) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 -$48.5K -$608K -$80.5K -15.2% Jul 1, 2025 Sep 30, 2025 10-Q 2025-11-14
Q2 2025 $32K -$1.67K -$265K -101% Apr 1, 2025 Jun 30, 2025 10-Q 2025-08-14
Q1 2025 $297K $78.6K +$688K Jan 1, 2025 Mar 31, 2025 10-Q 2025-07-21
Q4 2024 -$391K $483K +$687K Oct 1, 2024 Dec 31, 2024 10-K 2025-06-30
Q3 2024 -$1.08M -$528K -$71K -15.6% Jul 1, 2024 Sep 30, 2024 10-Q 2025-11-14
Q2 2024 -$1.01M $263K +$195K +285% Apr 1, 2024 Jun 30, 2024 10-Q 2025-08-14
Q1 2024 -$1.2M -$609K -$26.4K -4.52% Jan 1, 2024 Mar 31, 2024 10-Q 2025-07-21
Q4 2023 -$1.17M -$204K -$41.9K -25.8% Oct 1, 2023 Dec 31, 2023 10-K 2025-06-30
Q3 2023 -$1.13M -$457K -$783K -240% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-14
Q2 2023 -$350K $68.4K +$49.1K +255% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-14
Q1 2023 -$400K -$583K -$1.27M -185% Jan 1, 2023 Mar 31, 2023 10-Q 2024-07-02
Q4 2022 $873K -$162K -$594K -138% Oct 1, 2022 Dec 31, 2022 10-K 2024-04-08
Q3 2022 $1.47M $326K -$1.45M -81.6% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 $2.91M $19.2K -$1.98M -99% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 $4.89M $690K +$119K +20.8% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 $4.77M $432K Oct 1, 2021 Dec 31, 2021 10-K 2023-05-02
Q3 2021 $1.77M +$6.17M Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 $2M +$18M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 $571K +$660K Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-13
Q3 2020 -$19.9M -$4.39M -$4.33M -6635% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 -$15.5M -$16M -$16.1M -23303% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-16
Q1 2020 $550K -$89.6K -$161K -226% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-14
Q4 2019 $711K $636K -$320K -33.4% Oct 1, 2019 Dec 31, 2019 10-K 2020-03-31
Q3 2019 $1.03M -$65.2K -$82.5K -478% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-12
Q2 2019 $1.11M $69K +$47.2K +217% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-14
Q1 2019 $1.07M $71.3K +$45.3K +174% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-01
Q4 2018 $1.02M $956K +$935K +4622% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-31
Q3 2018 $85.2K $17.2K +$13.2K +322% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-14
Q2 2018 $72K $21.8K +$15.4K +244% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-14
Q1 2018 $56.6K $26K +$18K +227% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-15
Q4 2017 $38.6K $20.2K +$9.83K +94.4% Oct 1, 2017 Dec 31, 2017 10-K 2019-04-01
Q3 2017 $28.8K $4.08K -$9.16K -69.2% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-09
Q2 2017 $37.9K $6.33K -$10.3K -62% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-14
Q1 2017 $48.3K $7.95K -$13.8K -63.5% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-15
Q4 2016 $62.1K $10.4K -$70.4K -87.1% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-19
Q3 2016 $132K $13.2K -$15.2K -53.5% Jul 1, 2016 Sep 30, 2016 10-Q 2017-10-31
Q2 2016 $148K $16.7K +$14.6K +693% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-07
Q1 2016 $133K $21.8K +$12.5K +134% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-09
Q4 2015 $121K $80.8K Oct 1, 2015 Dec 31, 2015 10-K 2017-02-27
Q3 2015 $28.4K +$40.9K Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-07
Q2 2015 $2.1K Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-08
Q1 2015 $9.3K Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-09
Q3 2014 -$12.5K Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-10

Qualigen Therapeutics, Inc. Annual Nonoperating Income (Expense) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$391K +$784K +66.7% Jan 1, 2024 Dec 31, 2024 10-K 2025-06-30
2023 -$1.17M -$2.05M -235% Jan 1, 2023 Dec 31, 2023 10-K 2025-06-30
2022 $873K -$3.9M -81.7% Jan 1, 2022 Dec 31, 2022 10-K 2024-04-08
2021 $4.77M Jan 1, 2021 Dec 31, 2021 10-K 2023-05-02
2019 $711K -$309K -30.3% Jan 1, 2019 Dec 31, 2019 10-K 2020-03-31
2018 $1.02M +$982K +2544% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-31
2017 $38.6K -$23.5K -37.8% Jan 1, 2017 Dec 31, 2017 10-K 2019-04-01
2016 $62.1K -$58.5K -48.5% Jan 1, 2016 Dec 31, 2016 10-K 2018-03-19
2015 $121K +$312K Jan 1, 2015 Dec 31, 2015 10-K 2017-02-27
2014 -$192K Jan 1, 2014 Dec 31, 2014 10-K 2016-03-21
* An asterisk sign (*) next to the value indicates that the value is likely invalid.